VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > MedTech Malta 2024 this November! 🚀

<< Previous

Bullboard Posts

Next >>

Comment by jopatcloon Sep 13, 2024 6:53am

60 Views

Post# 36221764

RE:MedTech Malta 2024 this November! 🚀

Interesting more on
on site Angiopro

Our partners

Always be one step ahead – with patient screening software technologies before and after cardiovascular interventions.

We support high-tech imaging software in cardiovascular medicine under the brand names Caas, 3mensio and Ventripoint. Select a product group to find out more information about the workflow.